Vascular Graft Solutions

📍 Tel-Aviv, Israel🗓 Founded 2009👥 27 employees💰 Last funded Jul 2018
Medical Equipment Manufacturing🌐 graftsolutions.com
Website LinkedIn
Vascular Graft Solutions (VGS), was founded in 2009 and is focusing on the development and commercialization of innovative solutions to improve the outcome of bypass surgeries. The company’s leading product, the VEST (Venous External Scaffolding Technology), is a novel external mechanical support for autologous vein grafts, intended for improving vein graft longevity. Pre-clinical and clinical studies confirmed that by restraining wall tension and improving lumen uniformity, the VEST optimizes vein graft hemodynamics and mitigates vein graft disease. Randomized controlled trials and real-world data studies in Europe, demonstrated the biomechanical effect of external stenting, its statistically significant mitigation of vein graft disease, and improved clinical outcomes.
3
Total investors
1
Early stage
1
Mid stage
1
Late stage
2009
Founded

Investors

3 investors
All
Early stage
Mid stage
Late stage
Investor geography2 countries
United States
1
Switzerland
1
Investor activity2010–2018 · investors recorded per year
201012012120181
Recent (last 2y)Earlier
Frequently asked questions
Who invested in Vascular Graft Solutions?
Vascular Graft Solutions has 3 investors on record on gritt.io, including 1 early-stage backers, 1 mid-stage and 1 late-stage investors.
When did Vascular Graft Solutions last raise funding?
The most recent investment in Vascular Graft Solutions recorded on gritt.io was in July 2018.
When was Vascular Graft Solutions founded?
Vascular Graft Solutions was founded in 2009.
What industry is Vascular Graft Solutions in?
Vascular Graft Solutions operates in Medical Equipment Manufacturing. Find similar Medical Equipment Manufacturing investors on gritt.io.
Where is Vascular Graft Solutions based?
Vascular Graft Solutions is headquartered in Tel-Aviv, Israel.